Supplementary Tables 1-3, Supplementary Figures 1-5 from Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition

Bo Pang,Nan Wu,Rongwei Guan,Lin Peng,Xinlei Li,Su Li,Liudi Tang,Ying Guo,Jialei Chen,Donglin Sun,Huiling Sun,Jialin Dai,Jing Bai,Guohua Ji,Peng Liu,An Liu,Qiushi Wang,Shifu Xiao,Songbin Fu,Jun Yan

DOI: https://doi.org/10.1158/1078-0432.22468584

2023-01-01

Abstract:Table S1: Primary antibodies used for western blot analysis; Table S2: Univariate and multivariate Cox regression analysis of different prognosis factors in patients with LUAD from TMAS; Table S3: related to Figure 4 and 6. Correlation between expression of RCC2and EMT markers and between expression of RCC2 and p-JNK inLUAD; Supplementary Figure 1. Verifying specificity of anti-RCC2 antibody; Supplementary Figure 2 (related to Figure 1). Kaplan-Meier survival analysis according to RCC2 expression in 204 LUAD patients of GEO dataset(GSE31210) from PrognoScan(log-rank test); Supplementary Figure 3 (related to Figure 4). Representative IHC staining for RCC2, N-cadherin, α-SMA, β-catenin, and E-cadherinin serial sections of patients with LUAD; Supplementary Figure 4 (related to Figure 5). Knockdown of RCC2 suppressed xenograft tumor growth in vivo; Supplementary Figure 5 (related to Figure 6) Representative IHC staining for RCC2 and p-JNK in serial sections of LUAD patients.